PICH Childhood Asthma project Bina Chauhan Locum GP 4/5/16.

Slides:



Advertisements
Similar presentations
Respiratory Care in Children Better Care for Better Outcomes Dr Duncan Keeley GP Thame Thames Valley Strategic Clinical Network.
Advertisements

Steps to better asthma care A guide for primary care.
2012 UPDATE. What guidelines do we have available to follow for asthma 1) Asthma GP monitoring Guideline 2) Asthma Diagnosis Guideline 3) Acute asthma.
Mark L Levy Clinical Lead National Review of Asthma Deaths (NRAD) An overview Rosie Houston Programme Manager.
2008 Guidelines 2.4 DIAGNOSIS IN ADULTS (1) -based on the recognition of a characteristic pattern of symptoms and signs and the absence of an alternative.
Nabeela Bari Savitha Pushparajah GP respiratory leads.
Global Initiative for Asthma (GINA) What’s new in GINA 2015?
Learning objectives:- 1. Introduction. 2. Define health record. 3. Explain types of health record. 4. Mention purposes of health record. 5. List general.
Acute severe asthma.
Copyright restrictions may apply JAMA Pediatrics Journal Club Slides: Nebulized Hypertonic Saline for Bronchiolitis Florin TA, Shaw KN, Kittick M, Yakscoe.
Asthma Diagnosis Prescribing Acute Management Tracey Bradshaw Respiratory Consultant RIE.
Managing asthma & Inhaler devices for respiratory disease.
Inhaler technique is it important?. Compton et al (2006) Review of evidence from 6 European countries ( Spain, Italy, France, Germany, Netherlands, UK)
Triage Nurse Initiation of Corticosteroids in Paediatric Asthma is Associated With Improved Emergency Department Efficiency Zemak et al Pediatrics Volume.
22/06/2011.  Asthma – an introduction (Vanessa)  Diagnosis and management of chronic asthma in line with current BTS guidelines (Dr Lowery)  3 x Case.
British Guideline on the Management of Asthma. Aims Review of current SIGN/BTS guidelines –Diagnosing Asthma –Stepwise management of Asthma –Managing.
Respiratory illness in children asthma standards of care
6 th May 2014 Dr. James Paton University of Glasgow, Clinical Audit Lead, RCPCH NRAD and Children What the Report Means for Paediatric Care.
Asthma Management Fine Tuning  Maximum control with minimum medication  Start with mild asthma and work up the scale (BTS/SIGN 2004)
Palivizumab: a centralised clinic Laura Marshall RCN Conference 13 th March 2008.
Bronchial Asthma  Definition  Patho-physiology  Diagnosis  Management.
Prescribing Errors in General Practice The PRACtICe Study (2012) GMC Investigating Prevalence and Causes.
Asthma in children Dr Gulamabbas Khakoo BMBCh, FRCPCH
Budesonide/formoterol as effective as prednisolone plus formoterol in acute exacerbations of COPD A double-blind, randomised, non-inferiority, parallel-group,
Team Membership Dee Kaupie RCP, AE-C Sandy Swanson, RN Michael Wall, PharmD Kathleen Webster, MD Children's Asthma Care Core Measures Confidential: For.
Assessing Control & Adjusting Therapy in Youths > 12 Years of Age & Adults *ACQ values of 0.76–1.4 are indeterminate regarding well-controlled asthma.
1 Asthma October 30, Weiss, Gergen, & Hodgson (1992)2 Pediatric Statistics Prevalence increasing School absences Estimated as more than 10 million.
What would be the most usual abnormal PE finding among asthma suspects? A. Wheezing on auscultation B. Wheezing only on forcible exhalation C. Absence.
Acute and chronic management of childhood asthma
Western NSW Integrated Care Strategy To transform existing services into an integrated Western NSW system of care that is tailored to the needs of our.
Improving the effectiveness of integrated care teams Rob Darracott Pharmacy Voice.
GP Asthma Symposium Dr Max Matonhodze M A Med Ed (Keele), FRCP ( London) Consultant Physician and Asthma Lead Walsall Healthcare NHS Trust.
Exacerbations. Exacerbations An exacerbation of COPD is an acute event characterized by a worsening of the patient’s respiratory symptoms that is beyond.
Asthma management across ages Acute asthma What is the difference between acute and brittle asthma??
Component 4 Medications. Key Points - Medications  2 general classes: – Long-term control medications – Quick-Relief medications  Controller medications:
History Taking Zinc code: UKACL1878ea Date of preparation May 2015 AstraZeneca provided funding & reviewed for technical accuracy.
ASTHMA MANAGEMENT AND PREVENTION PREFACE Asthma affects an estimated 300 million individuals worldwide. Serious global health problem affecting all age.
Asthma Guidelines, Diagnosis and Management Alison Hughes Respiratory Specialist Nurse Solent NHS Trust.
Wendy Pigg Practice support Pharmacist/Independent Prescriber
Long-term Mortality Among Adults With Asthma A 25-Year Follow-up of 1,075 Outpatients With Asthma Zarqa Ali, MD; Christina Glattre Dirks, MD, PhD; and.
A STHMA MANAGEMENT IN CHILDREN AND THE ROLE OF THE NURSE SPECIALIST Amanda Jones Paediatric Respiratory Nurse Specialist Childrens Community Team.
Evelina London Child Health Programme Integrating services Claire Lemer 29 th April 2014.
Asthma Kills Sophie Toor
l asthma nnovation in quality improvement of care in children
Jessica Case study.
National Review of Asthma Deaths (NRAD)
MODERATE & ACUTE SEVERE ASTHMA
Respiratory disorders
Research where it is most needed National Respiratory Strategy
Adult Asthma Report 5 Coles Lane, Oakington, Cambridge, CB24 3BA.
Child Asthma Report 5 Coles Lane, Oakington, Cambridge, CB24 3BA.
Monitoring asthma in primary care
Global Initiative for Asthma (GINA) What’s new in GINA 2015?
MUR and NMS Respiratory Toolkit.
Asthma & Pre-school wheeze Management Plan
Schools Emergency Asthma Initiative Wandsworth and Merton
Introduction Where did it come from? Started approximately 5 years ago
Asthma Friendly Schools ASSEMBLY FOR SECONDARY
12 months before treatment 12 months after treatment
Dr Mark L Levy’s EMIS Asthma Template
  Is school based directly observed therapy (DOT) in asthma always effective? (The Good, the Bad and the Ugly of DOT). Author: S Frost, J Bennett, T Evans,
Compliance With NICE Guidelines for Children At Risk of Anaphylaxis In a Tertiary Allergy Centre Thaventhiran, P and Benjamin, L Children’s Allergy Service.
Respiratory disorders
Childhood Asthma : Lessons still to be learnt
Global Initiative for Asthma (GINA) What’s new in GINA 2015?
West Essex Frailty Pathway: COPD
The efficacy and safety of omalizumab in pediatric allergic asthma
Asthma Education for Families and HCPs
Introduction Project At Crown Street Surgery:
Shortness of breath & the child with wheeze
Presentation transcript:

PICH Childhood Asthma project Bina Chauhan Locum GP 4/5/16

Why asthma? Asthma deaths are preventable. 1.1 million children in the UK are currently receiving treatment for asthma (1 in 11) 1 A child is admitted to hospital every 20 minutes because of an asthma attack. Attacks are often treated as isolated events without follow-up or optimisation of chronic treatment. 2 Asthma A&E attendances in Harrow as significantly worse than the average for England asthma.org.uk 2. GINA 3. Chimat profiles

National review of asthma deaths NRAD 2012 identified a number of preventable factors: – Excessive relievers/insufficient preventers – Failure to provide personal asthma plans – Attacks may have resulted from inadequate tx or education recognising danger signs Asthma attacks indicate a failure to control disease, by health professional or patients.

What I would like to achieve Better asthma education for children, families and local GPs. Personalised and realistic action plans to improve overall control. Better recognition and treatment of acute exacerbations. Improved shared care between primary and secondary care.

Aim of baseline audit To investigate the assessment and management of asthma exacerbations in children and young people age 0-19 years over a 6 month period between 1/4/15 – 1/10/15. To assess routine asthma management prior to an exacerbation. To help practices quickly determine whether there were preventable factors that could have helped patients avoid attacks and therefore helped to avoid an admission. Presented at practice meeting.

Standards London asthma standards Global Initiative for Asthma (GINA) – BTS/SIGN

Audit criteria to be measured 1. Existing asthma treatment before the attack: – Reliever – Preventer – Spacer? 2. Prescribing in 12 months before the attack: – Number of relievers prescribed – Number of preventers prescribed 3. Last routine asthma review: – Date – Control assessed? If yes, poor or good? – Risk factors identified? If yes, which? – Inhaler technique checked? If yes, poor or good? – Record of previous best peak flow? If yes, what was it? 4. Personal asthma action plan 5. Assessment and treatment during the attack: – Peak flow measured? – Sa02 measured? If yes, before and after treatment? – Salbutamol given? If yes, neb or spacer? Oxygen or air? – Prednisolone prescribed? If yes, dose and duration? 6. Date reviewed after attack

Methodology Emis search for CYP age 0-19 years at Simpson House Medical Centre, Harrow ReadCode searches for: Asthma, wheeze, asthma exacerbation Time frame: 1/4/15 – 1/10/15 (6 months retrospective)

Results, Summary & Discussion General standards: All CYP prescribed more than 6 short acting bronchodilator reliever inhalers (SABAs) in the previous year should also be prescribed inhaled corticosteroids (or have a record detailing why this is not justified) All CYP with asthma should have evidence of being provided a Personal Asthma Action Plan (detailing medication administration, trigger factors and their avoidance, identification of danger signs of attacks, and what to do when these occur) All CYP over 5 years should have a record of their best Peak Expiratory Flow All CYP prescribed inhalers must have evidence in their records of having their inhaler technique assessed During attacks: All CYP should have a measurement of oxygen saturation, repeated after treatment if abnormal. All CYP over age 5 years should have a measurement of Peak Flow (to include one after first dose of oral steroid treatment to assess whether treatment was successful) After treatment of the attack: All CYP prescribed oral corticosteroids should be reviewed within 2 working days of starting treatment with oral corticosteroids.

3/12 (25%) patients were prescribed 6 or more SABAs in the 12 months before, they were all prescribed ICS, however all three were poorly controlled when they had their last asthma assessment, indicating their treatment needed optimising. Two of the three had their inhaler technique checked, and one of these was poor, probably explaining why the patient was poorly controlled and had a subsequent attack

Summary & Discussion General standards: All CYP prescribed more than 6 short acting bronchodilator reliever inhalers (SABAs) in the previous year should also be prescribed inhaled corticosteroids (or have a record detailing why this is not justified) All CYP with asthma should have evidence of being provided a Personal Asthma Action Plan (detailing medication administration, trigger factors and their avoidance, identification of danger signs of attacks, and what to do when these occur) All CYP over 5 years should have a record of their best Peak Expiratory Flow All CYP prescribed inhalers must have evidence in their records of having their inhaler technique assessed During attacks: All CYP should have a measurement of oxygen saturation, repeated after treatment if abnormal. All CYP over age 5 years should have a measurement of Peak Flow (to include one after first dose of oral steroid treatment to assess whether treatment was successful) After treatment of the attack: All CYP prescribed oral corticosteroids should be reviewed within 2 working days of starting treatment with oral corticosteroids.

None of the 12 patients had evidence in their record of being provided with a personal asthma action plan

Summary & Discussion General standards: All CYP prescribed more than 6 short acting bronchodilator reliever inhalers (SABAs) in the previous year should also be prescribed inhaled corticosteroids (or have a record detailing why this is not justified) All CYP with asthma should have evidence of being provided a Personal Asthma Action Plan (detailing medication administration, trigger factors and their avoidance, identification of danger signs of attacks, and what to do when these occur) All CYP over 5 years should have a record of their best Peak Expiratory Flow All CYP prescribed inhalers must have evidence in their records of having their inhaler technique assessed During attacks: All CYP should have a measurement of oxygen saturation, repeated after treatment if abnormal. All CYP over age 5 years should have a measurement of Peak Flow (to include one after first dose of oral steroid treatment to assess whether treatment was successful) After treatment of the attack: All CYP prescribed oral corticosteroids should be reviewed within 2 working days of starting treatment with oral corticosteroids.

Only 3 of the 9 (over 5yrs) had a record of their best PEF

Summary & Discussion General standards: All CYP prescribed more than 6 short acting bronchodilator reliever inhalers (SABAs) in the previous year should also be prescribed inhaled corticosteroids (or have a record detailing why this is not justified) All CYP with asthma should have evidence of being provided a Personal Asthma Action Plan (detailing medication administration, trigger factors and their avoidance, identification of danger signs of attacks, and what to do when these occur) All CYP over 5 years should have a record of their best Peak Expiratory Flow All CYP prescribed inhalers must have evidence in their records of having their inhaler technique assessed During attacks: All CYP should have a measurement of oxygen saturation, repeated after treatment if abnormal. All CYP over age 5 years should have a measurement of Peak Flow (to include one after first dose of oral steroid treatment to assess whether treatment was successful) After treatment of the attack: All CYP prescribed oral corticosteroids should be reviewed within 2 working days of starting treatment with oral corticosteroids.

Only 3 of the 12 (25%) prescribed inhalers had evidence in their record of having had an inhaler technique check

Summary & Discussion General standards: All CYP prescribed more than 6 short acting bronchodilator reliever inhalers (SABAs) in the previous year should also be prescribed inhaled corticosteroids (or have a record detailing why this is not justified) All CYP with asthma should have evidence of being provided a Personal Asthma Action Plan (detailing medication administration, trigger factors and their avoidance, identification of danger signs of attacks, and what to do when these occur) All CYP over 5 years should have a record of their best Peak Expiratory Flow All CYP prescribed inhalers must have evidence in their records of having their inhaler technique assessed During attacks: All CYP should have a measurement of oxygen saturation, repeated after treatment if abnormal. All CYP over age 5 years should have a measurement of Peak Flow (to include one after first dose of oral steroid treatment to assess whether treatment was successful) After treatment of the attack: All CYP prescribed oral corticosteroids should be reviewed within 2 working days of starting treatment with oral corticosteroids.

Only 6/12 (50%) had their saturations checked. 1 was re checked after treatment.

Summary & Discussion General standards: All CYP prescribed more than 6 short acting bronchodilator reliever inhalers (SABAs) in the previous year should also be prescribed inhaled corticosteroids (or have a record detailing why this is not justified) All CYP with asthma should have evidence of being provided a Personal Asthma Action Plan (detailing medication administration, trigger factors and their avoidance, identification of danger signs of attacks, and what to do when these occur) All CYP over 5 years should have a record of their best Peak Expiratory Flow All CYP prescribed inhalers must have evidence in their records of having their inhaler technique assessed During attacks: All CYP should have a measurement of oxygen saturation, repeated after treatment if abnormal. All CYP over age 5 years should have a measurement of Peak Flow (to include one after first dose of oral steroid treatment to assess whether treatment was successful) After treatment of the attack: All CYP prescribed oral corticosteroids should be reviewed within 2 working days of starting treatment with oral corticosteroids.

Only 3 of the 9 (30%) had PEF measured before treatment and none after.

Summary & Discussion General standards: All CYP prescribed more than 6 short acting bronchodilator reliever inhalers (SABAs) in the previous year should also be prescribed inhaled corticosteroids (or have a record detailing why this is not justified) All CYP with asthma should have evidence of being provided a Personal Asthma Action Plan (detailing medication administration, trigger factors and their avoidance, identification of danger signs of attacks, and what to do when these occur) All CYP over 5 years should have a record of their best Peak Expiratory Flow All CYP prescribed inhalers must have evidence in their records of having their inhaler technique assessed During attacks: All CYP should have a measurement of oxygen saturation, repeated after treatment if abnormal. All CYP over age 5 years should have a measurement of Peak Flow (to include one after first dose of oral steroid treatment to assess whether treatment was successful) After treatment of the attack: All CYP prescribed oral corticosteroids should be reviewed within 2 working days of starting treatment with oral corticosteroids.

Not one of the CYP had an assessment within a few days after the attack – this included the child who by BTS/SIGN definition had a life threatening attack (SaO2 92% before and after initial treatment) This review should include checking inhaler technique, whether a Personal Asthma Action Plan has been issued or needs modifying, and what triggered the attack. Oral Corticosteroids should be continued until the attack has resolved (as determined by the health professional)

Patient experience and involvement – Asthma plans with longer appointments – Mini focus groups Data influencing change – Audit results to aid improvement for 1 practice Working clinically in an integrated way – Respiratory lead for Harrow CCG – Asthma nurse Leading the development of integrated services – Working towards increased nurse involvement to help follow up post A&E attendance. – Better communication A&E and GP with shared care

The next step Face to face asthma plans for the 12 identified children with the asthma nurse present. Re audit in June (3 months retrospective) following GP education/presentation. Continued working towards more integrated services: – ? A dedicated post exacerbation clinic – ? Targeting repeat A&E attenders